The FDA has rescheduled a meeting of its Food AdvisoryCommittee to review Calgene Inc's Flavr Savr tomato on April6-8, the Davis, Calif., company (NASDAQ:CGNE) announcedMonday.
The FDA had initially said it would review the geneticallyengineered tomato on March 9 and 10, but in early Februarythe agency postponed the meeting.
The Food Advisory Committee provides advice on emergingfood safety, food science and nutrition issues that FDAconsiders of primary importance in the next decade.
(c) 1997 American Health Consultants. All rights reserved.